Listed

Xtant Medical Holdings, Inc.

XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31

Reports and events: 545 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Xtant Medical Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2018-09-1911:03 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000751
2018-09-1707:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-013320
2018-08-2016:11 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-012342
2018-08-0816:18 ET10-QQuarterly reportPeriod 2018-06-300001493152-18-011170
2018-08-0717:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-18-011100
2018-08-0316:38 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-18-010957
2018-07-1006:40 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-009846
2018-06-2607:43 ETDEF 14AProxy statementPeriod 2018-06-260001493152-18-009197
2018-06-1908:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-008885
2018-05-3016:22 ETS-1/ARegistration statement, amended0001144204-18-031665
2018-05-2107:35 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-029946
2018-05-1816:26 ET8-K8.01 Other events0001144204-18-029837
2018-05-1616:17 ETS-1/ARegistration statement, amended0001144204-18-029220
2018-05-1516:19 ETS-1Registration statement0001144204-18-028900
2018-05-0816:39 ET10-QQuarterly reportPeriod 2018-03-310001144204-18-026164
2018-04-1819:19 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-021015
2018-04-1819:12 ETS-1/ARegistration statement, amended0001144204-18-021010
2018-04-0515:06 ET10-K/AAnnual report, amendedPeriod 2017-12-310001144204-18-019363
2018-04-0306:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-018804
2018-04-0217:28 ET10-KAnnual reportPeriod 2017-12-310001144204-18-018725
2018-03-3017:26 ET10-Q/AQuarterly report, amendedPeriod 2017-06-300001144204-18-018329
2018-03-3017:25 ET10-Q/AQuarterly report, amendedPeriod 2017-03-310001144204-18-018327
2018-03-2707:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-017015
2018-02-1616:05 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-009541
2018-02-1516:30 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000155
2018-02-1507:00 ET8-K8.01 Other events0001144204-18-009155
2018-02-1317:30 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-008047
2018-02-0717:30 ETS-1Registration statement0001144204-18-006371
2018-01-3112:48 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-18-004833
2018-01-2310:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-003172
2018-01-2214:24 ETDEF 14AProxy statementPeriod 2018-02-130001144204-18-003037
2018-01-1811:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-18-002596
2018-01-1717:19 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000043
2018-01-1221:50 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001144204-18-001982
2018-01-0215:36 ET8-K5.07 Shareholder vote results0001144204-18-000194
2017-12-2916:49 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-17-065910
2017-12-0815:13 ETDEF 14AProxy statementPeriod 2017-12-290001144204-17-062947
2017-12-0408:32 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-17-062064
2017-11-2116:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-060445
2017-11-2108:49 ET10-QQuarterly reportPeriod 2017-09-300001144204-17-060277
2017-11-2017:16 ET8-K4.02 Non-reliance on financial statements0001144204-17-060210
2017-11-1416:25 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-17-059058
2017-11-0907:40 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-057434
2017-11-0614:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001144204-17-056465
2017-10-3116:48 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-17-055181
2017-10-3118:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001552781-17-000593
2017-10-2516:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001552781-17-000581
2017-10-0611:14 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001552781-17-000541
2017-10-0309:25 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001144204-17-051060
2017-09-1408:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001552781-17-000524

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.